Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 2	2026-07-23		NCT07711314

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shengli Oilfield Hospital	12
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	164
The Second Hospital of Anhui Medical University	34

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Nanjing Drum Tower Hospital, Affilitated Hospital of Medical School, Nanjing University	Nanjing	China	1